Probiotic Beverage Market by Type (Fruit Based and Dairy Based) by Product (Yogurt, Kefir, Probugs and Others) by Strains (Lactobacillus Casei Immunitas, L. casei Shirota, Lactobacillus Johnsonii, Lactobacillus Helveticus, Lactobacillus Reuteri MM53, Lactobacillus Rhamnosus GG and Propionibacterium Freudenreichii ssp. Shermanii JS and Others), by Indication (Alleviation of Lactose-intolerance Symptoms, Treatment of Viral and Antibiotic-associated Diarrhea, Reduction in Symptoms of Antibiotic Treatment of Helicobacter Pylori, Alleviation of Atopic Dermatitis Symptoms in Children, Prevention of the Risk of Allergy in Infancy, Inflammable Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS), Immune Response and Others) by Distribution Channel (Online, Offline (Supermarket, Hypermarket, Convenience Stores, Pharmacies and Retail Stores and Others)); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2020 - 2028
Industry Trends
Global probiotic beverage market was valued at US$ 10.68 billion in 2019 and is expected to reach US$ 35.09 billion by 2028, growing at a CAGR of 9.3% over the forecast period. Probiotic strains helps in successful digestion and avoids bacterial contamination, yeast infection and urinary tract infection. Probiotics are part of functional foods and beverages and help to enhance the gut functionality. Consumers have become more interested in drinking probiotic beverages as a means of enhancing their gut health, this drives the market for probiotic beverages and thus there is an increase in sale of these beverages over the years.
Dairy beverages have historically been fermented and used as yogurt, kefir, etc. These goods were commercialised and brought to the forefront due to the increasing knowledge of their quality. Due to broad acceptance and adoptability dairy drinks held the highest share in the industry. Adoption of food based beverages has also increased as these probiotic beverages have higher nutrient content. The factors promoting the growth of the global market for probiotic beverages are increasing personal disposable income along with increasing health awareness. In addition, it is also likely that the significant acceptance of probiotic juice drinks in single-serve packs will fuel development in the future. Increasing health awareness is the major factor driving the growth of the market, as the general population is becoming health conscious they are regularly engaged in adopting products that could improve immunity.
At present, the market is fragmented and is projected to remain the same over the forecast period. The market is witnessing partnerships between multiple suppliers to increase the quality of their goods and promote their products in the global market. Although growing understanding of probiotic beverages will give enormous opportunities for growth of the market but differing opinions of probiotic beverages will threaten the growth of market over the period.
Market vendors are concentrating more on the growth prospects in the dairy based segments to make the most of the opportunities, while retaining their positions in the market. One of the critical factors that will drive the growth of the probiotic drinks market over the forecast period is the rising awareness of probiotic beverages. Many manufacturers of probiotic beverages concentrate on creating and launching different types and flavours of probiotic drink products.
Via robust advertising campaigns they are also making efforts to communicate the health benefits of these goods. Beverage producers are now showcasing their products as ideal sources of probiotics, which helps to draw consumer interest significantly. If consumers become more conscious of probiotic beverages, the demand for these drinks will rise, leading to an increase in the size of the global market for probiotic beverages. Increased use of the product to preserve the natural balance of the organism in the intestines and avoid digestive issues, increased awareness among people about the nutritional value of the drink, growing preferences for healthy meals and food supplement & drinks will fuel the demand for probiotic beverages over the forecast period. Innovative products with various flavours and appealing packaging have been launched by the producers of probiotic beverages. Choosing a significant strain, however can be difficult for manufacturers as output standards differ with the other strains.
Type Insights
The development of probiotic beverages has been through fruits and dairy products from various market participants. Companies are working on creating products including probiotic strains with bases of dairy or fruits in order to create a palatable offering for the user. The development of newer products is expected to have a wider portfolio and create a comprehensive product line up for the users. Integration of various product forms are expected to help in growing the demand for market offerings across various regions.
Product Insights
The integration of probiotic substances in yogurt has been observed to be a key product over the years. Positive response to various yogurt-based products have led market participants to invest towards the same. Kefir, which is a similar product to yogurt is also utilized as a probiotic beverage option helping immunity improvements during infections for users. These products are expected to grow in terms of market share over the coming years due to improved marketing from companies and developments in product supply chains.
Strains Insights
The work undertaken by research institutes for developing various strains that help in improving the probiotic characteristics of the beverages have led to a widespread portfolio for the market. Strains including L. casei Shirota and Lactobacillus casei Immunitas among others are observed to be utilized by users across various regions. These factors from the supply and demand side are expected to help companies to invest towards strain research and create optimized products for the line-up. Market participants are expecting to have a surge in demand owing to their growing portfolio over the near future.
Indication Insights
It has been traditionally observed that users are enticed towards healthcare products only after they have suffered or are suffering from certain conditions. But, with the increasing efforts from various organizations regarding awareness improvement among the general population related to various medical conditions, adoption of preventive care has been growing over the years. Similar trends are observed in the probiotic beverages market as well. People suffering from conditions such as digestive system disorders, intolerance to certain substances, or allergies have been major users of probiotic beverages over the years. In addition to this, the growing awareness regarding immunity in the aftermath of the novel coronavirus is leading users to look towards products that help them in the same. Probiotic beverages are expected to be one of the notable immunity boosters and the demand for these products is expected to grow over the near future.
Distribution Channel Insights
The adoption of probiotic beverages across various countries has led market participants towards enhancing their supply chain. These initiatives are expected to help in serving the growing requirements of their customers. Advancements in solutions and services for supply chain optimization are leading companies to invest towards online and offline modes of distribution. The offline distribution mode has been helpful for market participants in countries with widespread network of retail stores and healthcare outlets. In countries wherein the market participants are not physically present, online distribution has helped in the growth of the market revenue. Strategic collaborations with distribution companies is helping the market participants to achieve positive trends in their market share. These initiatives are expected to grow the adoption of market offerings in newer countries and regions.
Regional Insights
The growing cases related to digestive system across various countries have created a load on the healthcare infrastructure in these regions. Various governing authorities and non-governmental organizations have been working on increasing the awareness amongst the population regarding digestive health and allied measures for maintaining the same. Probiotic beverages have been observed to be adopted majorly in developed countries primarily owing to significant awareness regarding the products from various market participants. North America is observed to be a major revenue contributor for the market. The countries in the region are seen to have a wide audience for various forms beverages and products that help in enhancing the immunity of the user. Asia Pacific is a region which portrays a growth in gastrointestinal disorders on a year over year basis. The adoption of probiotic beverages is growing in the region owing to higher demand from the working population in various countries. In addition to this, increasing ventures from market participants in the region with respect to manufacturing and distribution are expected to aid the growth of the revenue generation in the market over the forecast period.
Probiotic Beverage Market Revenue & Forecast, (US$ Million), 2020 – 2028
Competitive Landscape
The report provides both, qualitative and quantitative research probiotic beverage market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
The major players operating in the probiotic beverage market include Yakult, Amul, PepsiCo, Inc. (Kevita), Lifeway Foods, Inc., Nestle, Biogaia, Tine BA, Valio Ltd., NextFoods (Goodbelly), Danone S.A., Harmless Harvest, Bio-K Plus International Inc., Fonterra Co-operative Group Limited and other market participants.
Probiotic Beverage Market:
- By Type
- Fruit Based
- Dairy Based
- By Product
- Yogurt
- Kefir
- Probugs
- Others
- By Strains
- Lactobacillus Casei Immunitas
- L. casei Shirota
- Lactobacillus Johnsonii
- Lactobacillus Helveticus
- Lactobacillus Reuteri MM53
- Lactobacillus Rhamnosus GG and Propionibacterium Freudenreichii ssp. Shermanii JS
- Others
- By Indication
- Alleviation of Lactose-intolerance Symptoms
- Treatment of Viral and Antibiotic-associated Diarrhea
- Reduction in Symptoms of Antibiotic Treatment of Helicobacter Pylori
- Alleviation of Atopic Dermatitis Symptoms in Children
- Prevention of the Risk of Allergy in Infancy
- Inflammable Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS)
- Immune Response
- Others
- By Distribution Channel
- Online
- Offline
- Supermarket
- Hypermarket
- Convenience Stores
- Pharmacies and Retail Stores
- Others
- By Regio
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market
Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2018
1.2.2. Base
Year: 2019
1.2.3. Forecast
Years: 2020 – 2028
2. Key Target
Audiences
3. Research
Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations
and Insights from AMI’s Perspective**
5. Holistic
Overview of Probiotic Beverage Market
6. Market
Synopsis: Probiotic Beverage Market
7. Probiotic
Beverage Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Probiotic Beverage Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Probiotic Beverage Market
7.6. Porter’s Five Force Analysis
7.7. Impact of
Covid-19 on Probiotic Beverage Market
8. Global
Probiotic Beverage Market Analysis and Forecasts, 2020 – 2028
8.1. Overview
8.1.1. Global
Probiotic Beverage Market Revenue (US$ Mn)
8.2. Global
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
8.2.1. Fruit
Based
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2015 – 2019
8.2.1.3. Market
Forecast, 2020 – 2028
8.2.1.4. Compound
Annual Growth Rate (CAGR)
8.2.1.5. Regional
Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2015 – 2019
8.2.1.5.1.2. Market
Forecast, 2020 – 2028
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 – 2019
8.2.1.5.2.2. Market
Forecast, 2020 – 2028
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2015 – 2019
8.2.1.5.3.2. Market
Forecast, 2020 – 2028
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 – 2019
8.2.1.5.4.2. Market
Forecast, 2020 – 2028
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2015 – 2019
8.2.1.5.5.2. Market
Forecast, 2020 – 2028
8.2.2. Dairy
Based
8.2.2.1. Definition
8.2.2.2. Market
Estimation and Penetration, 2015 – 2019
8.2.2.3. Market
Forecast, 2020 – 2028
8.2.2.4. Compound
Annual Growth Rate (CAGR)
8.2.2.5. Regional
Bifurcation
8.2.2.5.1. North
America
8.2.2.5.1.1. Market
Estimation, 2015 – 2019
8.2.2.5.1.2. Market
Forecast, 2020 – 2028
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 – 2019
8.2.2.5.2.2. Market
Forecast, 2020 – 2028
8.2.2.5.3. Asia
Pacific
8.2.2.5.3.1. Market
Estimation, 2015 – 2019
8.2.2.5.3.2. Market
Forecast, 2020 – 2028
8.2.2.5.4. Middle
East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 – 2019
8.2.2.5.4.2. Market
Forecast, 2020 – 2028
8.2.2.5.5. Latin
America
8.2.2.5.5.1. Market
Estimation, 2015 – 2019
8.2.2.5.5.2. Market
Forecast, 2020 – 2028
8.3. Key Segment
for Channeling Investments
8.3.1. By Type
9. Global
Probiotic Beverage Market Analysis and Forecasts, 2020 – 2028
9.1. Overview
9.2. Global
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
9.2.1. Yogurt
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 – 2019
9.2.1.3. Market
Forecast, 2020 – 2028
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 – 2019
9.2.1.5.1.2. Market
Forecast, 2020 – 2028
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 – 2019
9.2.1.5.2.2. Market
Forecast, 2020 – 2028
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 – 2019
9.2.1.5.3.2. Market
Forecast, 2020 – 2028
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 – 2019
9.2.1.5.4.2. Market
Forecast, 2020 – 2028
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 – 2019
9.2.1.5.5.2. Market
Forecast, 2020 – 2028
9.2.2. Kefir
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 – 2019
9.2.2.3. Market
Forecast, 2020 – 2028
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 – 2019
9.2.2.5.1.2. Market
Forecast, 2020 – 2028
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 – 2019
9.2.2.5.2.2. Market
Forecast, 2020 – 2028
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 – 2019
9.2.2.5.3.2. Market
Forecast, 2020 – 2028
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 – 2019
9.2.2.5.4.2. Market
Forecast, 2020 – 2028
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 – 2019
9.2.2.5.5.2. Market
Forecast, 2020 – 2028
9.2.3. Probugs
9.2.3.1. Definition
9.2.3.2. Market
Estimation and Penetration, 2015 – 2019
9.2.3.3. Market
Forecast, 2020 – 2028
9.2.3.4. Compound
Annual Growth Rate (CAGR)
9.2.3.5. Regional
Bifurcation
9.2.3.5.1. North
America
9.2.3.5.1.1. Market
Estimation, 2015 – 2019
9.2.3.5.1.2. Market
Forecast, 2020 – 2028
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 – 2019
9.2.3.5.2.2. Market
Forecast, 2020 – 2028
9.2.3.5.3. Asia
Pacific
9.2.3.5.3.1. Market
Estimation, 2015 – 2019
9.2.3.5.3.2. Market
Forecast, 2020 – 2028
9.2.3.5.4. Middle
East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 – 2019
9.2.3.5.4.2. Market
Forecast, 2020 – 2028
9.2.3.5.5. Latin
America
9.2.3.5.5.1. Market
Estimation, 2015 – 2019
9.2.3.5.5.2. Market
Forecast, 2020 – 2028
9.2.4. Others
9.2.4.1. Definition
9.2.4.2. Market
Estimation and Penetration, 2015 – 2019
9.2.4.3. Market
Forecast, 2020 – 2028
9.2.4.4. Compound
Annual Growth Rate (CAGR)
9.2.4.5. Regional
Bifurcation
9.2.4.5.1. North
America
9.2.4.5.1.1. Market
Estimation, 2015 – 2019
9.2.4.5.1.2. Market
Forecast, 2020 – 2028
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 – 2019
9.2.4.5.2.2. Market
Forecast, 2020 – 2028
9.2.4.5.3. Asia
Pacific
9.2.4.5.3.1. Market
Estimation, 2015 – 2019
9.2.4.5.3.2. Market
Forecast, 2020 – 2028
9.2.4.5.4. Middle
East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 – 2019
9.2.4.5.4.2. Market
Forecast, 2020 – 2028
9.2.4.5.5. Latin
America
9.2.4.5.5.1. Market
Estimation, 2015 – 2019
9.2.4.5.5.2. Market
Forecast, 2020 – 2028
9.3. Key
Segment for Channeling Investments
9.3.1. By
Product
10. Global
Probiotic Beverage Market Analysis and Forecasts, 2020 – 2028
10.1. Overview
10.2. Global
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
10.2.1. Lactobacillus
casei Immunitas
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2015 – 2019
10.2.1.3. Market
Forecast, 2020 – 2028
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2015 – 2019
10.2.1.5.1.2. Market
Forecast, 2020 – 2028
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 – 2019
10.2.1.5.2.2. Market
Forecast, 2020 – 2028
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2015 – 2019
10.2.1.5.3.2. Market
Forecast, 2020 – 2028
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 – 2019
10.2.1.5.4.2. Market
Forecast, 2020 – 2028
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2015 – 2019
10.2.1.5.5.2. Market
Forecast, 2020 – 2028
10.2.2. L.
casei Shirota
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2015 – 2019
10.2.2.3. Market
Forecast, 2020 – 2028
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2015 – 2019
10.2.2.5.1.2. Market
Forecast, 2020 – 2028
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 – 2019
10.2.2.5.2.2. Market
Forecast, 2020 – 2028
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2015 – 2019
10.2.2.5.3.2. Market
Forecast, 2020 – 2028
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 – 2019
10.2.2.5.4.2. Market
Forecast, 2020 – 2028
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2015 – 2019
10.2.2.5.5.2. Market
Forecast, 2020 – 2028
10.2.3. Lactobacillus
johnsonii
10.2.3.1. Definition
10.2.3.2. Market
Estimation and Penetration, 2015 – 2019
10.2.3.3. Market
Forecast, 2020 – 2028
10.2.3.4. Compound
Annual Growth Rate (CAGR)
10.2.3.5. Regional
Bifurcation
10.2.3.5.1. North
America
10.2.3.5.1.1. Market
Estimation, 2015 – 2019
10.2.3.5.1.2. Market
Forecast, 2020 – 2028
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 – 2019
10.2.3.5.2.2. Market
Forecast, 2020 – 2028
10.2.3.5.3. Asia
Pacific
10.2.3.5.3.1. Market
Estimation, 2015 – 2019
10.2.3.5.3.2. Market
Forecast, 2020 – 2028
10.2.3.5.4. Middle
East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 – 2019
10.2.3.5.4.2. Market
Forecast, 2020 – 2028
10.2.3.5.5. Latin
America
10.2.3.5.5.1. Market
Estimation, 2015 – 2019
10.2.3.5.5.2. Market
Forecast, 2020 – 2028
10.2.4. Lactobacillus
helveticus
10.2.4.1. Definition
10.2.4.2. Market
Estimation and Penetration, 2015 – 2019
10.2.4.3. Market
Forecast, 2020 – 2028
10.2.4.4. Compound
Annual Growth Rate (CAGR)
10.2.4.5. Regional
Bifurcation
10.2.4.5.1. North
America
10.2.4.5.1.1. Market
Estimation, 2015 – 2019
10.2.4.5.1.2. Market
Forecast, 2020 – 2028
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 – 2019
10.2.4.5.2.2. Market
Forecast, 2020 – 2028
10.2.4.5.3. Asia
Pacific
10.2.4.5.3.1. Market
Estimation, 2015 – 2019
10.2.4.5.3.2. Market
Forecast, 2020 – 2028
10.2.4.5.4. Middle
East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 – 2019
10.2.4.5.4.2. Market
Forecast, 2020 – 2028
10.2.4.5.5. Latin
America
10.2.4.5.5.1. Market
Estimation, 2015 – 2019
10.2.4.5.5.2. Market
Forecast, 2020 – 2028
10.2.5. Lactobacillus
reuteri MM53
10.2.5.1. Definition
10.2.5.2. Market
Estimation and Penetration, 2015 – 2019
10.2.5.3. Market
Forecast, 2020 – 2028
10.2.5.4. Compound
Annual Growth Rate (CAGR)
10.2.5.5. Regional
Bifurcation
10.2.5.5.1. North
America
10.2.5.5.1.1. Market
Estimation, 2015 – 2019
10.2.5.5.1.2. Market
Forecast, 2020 – 2028
10.2.5.5.2. Europe
10.2.5.5.2.1. Market
Estimation, 2015 – 2019
10.2.5.5.2.2. Market
Forecast, 2020 – 2028
10.2.5.5.3. Asia
Pacific
10.2.5.5.3.1. Market
Estimation, 2015 – 2019
10.2.5.5.3.2. Market
Forecast, 2020 – 2028
10.2.5.5.4. Middle
East and Africa
10.2.5.5.4.1. Market
Estimation, 2015 – 2019
10.2.5.5.4.2. Market
Forecast, 2020 – 2028
10.2.5.5.5. Latin
America
10.2.5.5.5.1. Market
Estimation, 2015 – 2019
10.2.5.5.5.2. Market
Forecast, 2020 – 2028
10.2.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
10.2.6.1. Definition
10.2.6.2. Market
Estimation and Penetration, 2015 – 2019
10.2.6.3. Market
Forecast, 2020 – 2028
10.2.6.4. Compound
Annual Growth Rate (CAGR)
10.2.6.5. Regional
Bifurcation
10.2.6.5.1. North
America
10.2.6.5.1.1. Market
Estimation, 2015 – 2019
10.2.6.5.1.2. Market
Forecast, 2020 – 2028
10.2.6.5.2. Europe
10.2.6.5.2.1. Market
Estimation, 2015 – 2019
10.2.6.5.2.2. Market
Forecast, 2020 – 2028
10.2.6.5.3. Asia
Pacific
10.2.6.5.3.1. Market
Estimation, 2015 – 2019
10.2.6.5.3.2. Market
Forecast, 2020 – 2028
10.2.6.5.4. Middle
East and Africa
10.2.6.5.4.1. Market
Estimation, 2015 – 2019
10.2.6.5.4.2. Market
Forecast, 2020 – 2028
10.2.6.5.5. Latin
America
10.2.6.5.5.1. Market
Estimation, 2015 – 2019
10.2.6.5.5.2. Market
Forecast, 2020 – 2028
10.2.7. Others
10.2.7.1. Definition
10.2.7.2. Market
Estimation and Penetration, 2015 – 2019
10.2.7.3. Market
Forecast, 2020 – 2028
10.2.7.4. Compound
Annual Growth Rate (CAGR)
10.2.7.5. Regional
Bifurcation
10.2.7.5.1. North
America
10.2.7.5.1.1. Market
Estimation, 2015 – 2019
10.2.7.5.1.2. Market
Forecast, 2020 – 2028
10.2.7.5.2. Europe
10.2.7.5.2.1. Market
Estimation, 2015 – 2019
10.2.7.5.2.2. Market
Forecast, 2020 – 2028
10.2.7.5.3. Asia
Pacific
10.2.7.5.3.1. Market
Estimation, 2015 – 2019
10.2.7.5.3.2. Market
Forecast, 2020 – 2028
10.2.7.5.4. Middle
East and Africa
10.2.7.5.4.1. Market
Estimation, 2015 – 2019
10.2.7.5.4.2. Market
Forecast, 2020 – 2028
10.2.7.5.5. Latin
America
10.2.7.5.5.1. Market
Estimation, 2015 – 2019
10.2.7.5.5.2. Market
Forecast, 2020 – 2028
10.3. Key
Segment for Channeling Investments
10.3.1. By
Strains
11. Global
Probiotic Beverage Market Analysis and Forecasts, 2020 – 2028
11.1. Overview
11.2. Global
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
11.2.1. Alleviation
of lactose-intolerance symptoms
11.2.1.1. Definition
11.2.1.2. Market
Estimation and Penetration, 2015 – 2019
11.2.1.3. Market
Forecast, 2020 – 2028
11.2.1.4. Compound
Annual Growth Rate (CAGR)
11.2.1.5. Regional
Bifurcation
11.2.1.5.1. North
America
11.2.1.5.1.1. Market
Estimation, 2015 – 2019
11.2.1.5.1.2. Market
Forecast, 2020 – 2028
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 – 2019
11.2.1.5.2.2. Market
Forecast, 2020 – 2028
11.2.1.5.3. Asia
Pacific
11.2.1.5.3.1. Market
Estimation, 2015 – 2019
11.2.1.5.3.2. Market
Forecast, 2020 – 2028
11.2.1.5.4. Middle
East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 – 2019
11.2.1.5.4.2. Market
Forecast, 2020 – 2028
11.2.1.5.5. Latin
America
11.2.1.5.5.1. Market
Estimation, 2015 – 2019
11.2.1.5.5.2. Market
Forecast, 2020 – 2028
11.2.2. Treatment
of viral and antibiotic-associated diarrhea
11.2.2.1. Definition
11.2.2.2. Market
Estimation and Penetration, 2015 – 2019
11.2.2.3. Market
Forecast, 2020 – 2028
11.2.2.4. Compound
Annual Growth Rate (CAGR)
11.2.2.5. Regional
Bifurcation
11.2.2.5.1. North
America
11.2.2.5.1.1. Market
Estimation, 2015 – 2019
11.2.2.5.1.2. Market
Forecast, 2020 – 2028
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 – 2019
11.2.2.5.2.2. Market
Forecast, 2020 – 2028
11.2.2.5.3. Asia
Pacific
11.2.2.5.3.1. Market
Estimation, 2015 – 2019
11.2.2.5.3.2. Market
Forecast, 2020 – 2028
11.2.2.5.4. Middle
East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 – 2019
11.2.2.5.4.2. Market
Forecast, 2020 – 2028
11.2.2.5.5. Latin
America
11.2.2.5.5.1. Market
Estimation, 2015 – 2019
11.2.2.5.5.2. Market
Forecast, 2020 – 2028
11.2.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
11.2.3.1. Definition
11.2.3.2. Market
Estimation and Penetration, 2015 – 2019
11.2.3.3. Market
Forecast, 2020 – 2028
11.2.3.4. Compound
Annual Growth Rate (CAGR)
11.2.3.5. Regional
Bifurcation
11.2.3.5.1. North
America
11.2.3.5.1.1. Market
Estimation, 2015 – 2019
11.2.3.5.1.2. Market
Forecast, 2020 – 2028
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 – 2019
11.2.3.5.2.2. Market
Forecast, 2020 – 2028
11.2.3.5.3. Asia
Pacific
11.2.3.5.3.1. Market
Estimation, 2015 – 2019
11.2.3.5.3.2. Market
Forecast, 2020 – 2028
11.2.3.5.4. Middle
East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 – 2019
11.2.3.5.4.2. Market
Forecast, 2020 – 2028
11.2.3.5.5. Latin
America
11.2.3.5.5.1. Market
Estimation, 2015 – 2019
11.2.3.5.5.2. Market
Forecast, 2020 – 2028
11.2.4. Alleviation
of atopic dermatitis symptoms in children
11.2.4.1. Definition
11.2.4.2. Market
Estimation and Penetration, 2015 – 2019
11.2.4.3. Market
Forecast, 2020 – 2028
11.2.4.4. Compound
Annual Growth Rate (CAGR)
11.2.4.5. Regional
Bifurcation
11.2.4.5.1. North
America
11.2.4.5.1.1. Market
Estimation, 2015 – 2019
11.2.4.5.1.2. Market
Forecast, 2020 – 2028
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2015 – 2019
11.2.4.5.2.2. Market
Forecast, 2020 – 2028
11.2.4.5.3. Asia
Pacific
11.2.4.5.3.1. Market
Estimation, 2015 – 2019
11.2.4.5.3.2. Market
Forecast, 2020 – 2028
11.2.4.5.4. Middle
East and Africa
11.2.4.5.4.1. Market
Estimation, 2015 – 2019
11.2.4.5.4.2. Market
Forecast, 2020 – 2028
11.2.4.5.5. Latin
America
11.2.4.5.5.1. Market
Estimation, 2015 – 2019
11.2.4.5.5.2. Market
Forecast, 2020 – 2028
11.2.5. Prevention
of the risk of allergy in infancy
11.2.5.1. Definition
11.2.5.2. Market
Estimation and Penetration, 2015 – 2019
11.2.5.3. Market
Forecast, 2020 – 2028
11.2.5.4. Compound
Annual Growth Rate (CAGR)
11.2.5.5. Regional
Bifurcation
11.2.5.5.1. North
America
11.2.5.5.1.1. Market
Estimation, 2015 – 2019
11.2.5.5.1.2. Market
Forecast, 2020 – 2028
11.2.5.5.2. Europe
11.2.5.5.2.1. Market
Estimation, 2015 – 2019
11.2.5.5.2.2. Market
Forecast, 2020 – 2028
11.2.5.5.3. Asia
Pacific
11.2.5.5.3.1. Market
Estimation, 2015 – 2019
11.2.5.5.3.2. Market
Forecast, 2020 – 2028
11.2.5.5.4. Middle
East and Africa
11.2.5.5.4.1. Market
Estimation, 2015 – 2019
11.2.5.5.4.2. Market
Forecast, 2020 – 2028
11.2.5.5.5. Latin
America
11.2.5.5.5.1. Market
Estimation, 2015 – 2019
11.2.5.5.5.2. Market
Forecast, 2020 – 2028
11.2.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
11.2.6.1. Definition
11.2.6.2. Market
Estimation and Penetration, 2015 – 2019
11.2.6.3. Market
Forecast, 2020 – 2028
11.2.6.4. Compound
Annual Growth Rate (CAGR)
11.2.6.5. Regional
Bifurcation
11.2.6.5.1. North
America
11.2.6.5.1.1. Market
Estimation, 2015 – 2019
11.2.6.5.1.2. Market
Forecast, 2020 – 2028
11.2.6.5.2. Europe
11.2.6.5.2.1. Market
Estimation, 2015 – 2019
11.2.6.5.2.2. Market
Forecast, 2020 – 2028
11.2.6.5.3. Asia
Pacific
11.2.6.5.3.1. Market
Estimation, 2015 – 2019
11.2.6.5.3.2. Market
Forecast, 2020 – 2028
11.2.6.5.4. Middle
East and Africa
11.2.6.5.4.1. Market
Estimation, 2015 – 2019
11.2.6.5.4.2. Market
Forecast, 2020 – 2028
11.2.6.5.5. Latin
America
11.2.6.5.5.1. Market
Estimation, 2015 – 2019
11.2.6.5.5.2. Market
Forecast, 2020 – 2028
11.2.7. Immune
Response
11.2.7.1. Definition
11.2.7.2. Market
Estimation and Penetration, 2015 – 2019
11.2.7.3. Market
Forecast, 2020 – 2028
11.2.7.4. Compound
Annual Growth Rate (CAGR)
11.2.7.5. Regional
Bifurcation
11.2.7.5.1. North
America
11.2.7.5.1.1. Market
Estimation, 2015 – 2019
11.2.7.5.1.2. Market
Forecast, 2020 – 2028
11.2.7.5.2. Europe
11.2.7.5.2.1. Market
Estimation, 2015 – 2019
11.2.7.5.2.2. Market
Forecast, 2020 – 2028
11.2.7.5.3. Asia
Pacific
11.2.7.5.3.1. Market
Estimation, 2015 – 2019
11.2.7.5.3.2. Market
Forecast, 2020 – 2028
11.2.7.5.4. Middle
East and Africa
11.2.7.5.4.1. Market
Estimation, 2015 – 2019
11.2.7.5.4.2. Market
Forecast, 2020 – 2028
11.2.7.5.5. Latin
America
11.2.7.5.5.1. Market
Estimation, 2015 – 2019
11.2.7.5.5.2. Market
Forecast, 2020 – 2028
11.2.8. Others
11.2.8.1. Definition
11.2.8.2. Market
Estimation and Penetration, 2015 – 2019
11.2.8.3. Market
Forecast, 2020 – 2028
11.2.8.4. Compound
Annual Growth Rate (CAGR)
11.2.8.5. Regional
Bifurcation
11.2.8.5.1. North
America
11.2.8.5.1.1. Market
Estimation, 2015 – 2019
11.2.8.5.1.2. Market
Forecast, 2020 – 2028
11.2.8.5.2. Europe
11.2.8.5.2.1. Market
Estimation, 2015 – 2019
11.2.8.5.2.2. Market
Forecast, 2020 – 2028
11.2.8.5.3. Asia
Pacific
11.2.8.5.3.1. Market
Estimation, 2015 – 2019
11.2.8.5.3.2. Market
Forecast, 2020 – 2028
11.2.8.5.4. Middle
East and Africa
11.2.8.5.4.1. Market
Estimation, 2015 – 2019
11.2.8.5.4.2. Market
Forecast, 2020 – 2028
11.2.8.5.5. Latin
America
11.2.8.5.5.1. Market
Estimation, 2015 – 2019
11.2.8.5.5.2. Market
Forecast, 2020 – 2028
11.3. Key
Segment for Channeling Investments
11.3.1. By
Indication
12. Global
Probiotic Beverage Market Analysis and Forecasts, 2020 – 2028
12.1. Overview
12.2. Global
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.2.1. Online
12.2.1.1. Definition
12.2.1.2. Market
Estimation and Penetration, 2015 – 2019
12.2.1.3. Market
Forecast, 2020 – 2028
12.2.1.4. Compound
Annual Growth Rate (CAGR)
12.2.1.5. Regional
Bifurcation
12.2.1.5.1. North
America
12.2.1.5.1.1. Market
Estimation, 2015 – 2019
12.2.1.5.1.2. Market
Forecast, 2020 – 2028
12.2.1.5.2. Europe
12.2.1.5.2.1. Market
Estimation, 2015 – 2019
12.2.1.5.2.2. Market
Forecast, 2020 – 2028
12.2.1.5.3. Asia
Pacific
12.2.1.5.3.1. Market
Estimation, 2015 – 2019
12.2.1.5.3.2. Market
Forecast, 2020 – 2028
12.2.1.5.4. Middle
East and Africa
12.2.1.5.4.1. Market
Estimation, 2015 – 2019
12.2.1.5.4.2. Market
Forecast, 2020 – 2028
12.2.1.5.5. Latin
America
12.2.1.5.5.1. Market
Estimation, 2015 – 2019
12.2.1.5.5.2. Market
Forecast, 2020 – 2028
12.2.2. Offline
(Definition, Market Estimation and Penetration, 2015 – 2019, Market Estimation
(2015 – 2019), Market Forecast (2020 – 2028), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Supermarket, Hypermarket,
Convenience Stores, Pharmacies and Retail Stores, Others)
12.2.2.1. Supermarket
12.2.2.2. Hypermarket
12.2.2.3. Convenience
Stores
12.2.2.4. Pharmacies
and Retail Stores
12.2.2.5. Others
12.3. Key
Segment for Channeling Investments
12.3.1. By
Distribution Channel
13. North
America Probiotic Beverage Market Analysis and Forecasts, 2020 - 2028
13.1. Overview
13.1.1. North
America Probiotic Beverage Market Revenue (US$ Mn)
13.2. North
America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
13.2.1. Fruit
Based
13.2.2. Dairy
Based
13.3. North
America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
13.3.1. Yogurt
13.3.2. Kefir
13.3.3. Probugs
13.3.4. Others
13.4. North
America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
13.4.1. Lactobacillus
casei Immunitas
13.4.2. L.
casei Shirota
13.4.3. Lactobacillus
johnsonii
13.4.4. Lactobacillus
helveticus
13.4.5. Lactobacillus
reuteri MM53
13.4.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
13.4.7. Others
13.5. North
America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
13.5.1. Alleviation
of lactose-intolerance symptoms
13.5.2. Treatment
of viral and antibiotic-associated diarrhea
13.5.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
13.5.4. Alleviation
of atopic dermatitis symptoms in children
13.5.5. Prevention
of the risk of allergy in infancy
13.5.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
13.5.7. Immune
Response
13.5.8. Others
13.6. North
America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
13.6.1. Online
13.6.2. Offline
13.6.2.1. Supermarket
13.6.2.2. Hypermarket
13.6.2.3. Convenience
Stores
13.6.2.4. Pharmacies
and Retail Stores
13.6.2.5. Others
13.7. North
America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Country
13.7.1. U.S
13.7.1.1. U.S
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
13.7.1.1.1. Fruit
Based
13.7.1.1.2. Dairy
Based
13.7.1.2. U.S Probiotic
Beverage Market Revenue (US$ Mn) and Forecasts, By Product
13.7.1.2.1. Yogurt
13.7.1.2.2. Kefir
13.7.1.2.3. Probugs
13.7.1.2.4. Others
13.7.1.3. U.S
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
13.7.1.3.1. Lactobacillus
casei Immunitas
13.7.1.3.2. L.
casei Shirota
13.7.1.3.3. Lactobacillus
johnsonii
13.7.1.3.4. Lactobacillus
helveticus
13.7.1.3.5. Lactobacillus
reuteri MM53
13.7.1.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
13.7.1.3.7. Others
13.7.1.4. U.S
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
13.7.1.4.1. Alleviation
of lactose-intolerance symptoms
13.7.1.4.2. Treatment
of viral and antibiotic-associated diarrhea
13.7.1.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
13.7.1.4.4. Alleviation
of atopic dermatitis symptoms in children
13.7.1.4.5. Prevention
of the risk of allergy in infancy
13.7.1.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
13.7.1.4.7. Immune
Response
13.7.1.4.8. Others
13.7.1.5. U.S
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.7.1.5.1. Online
13.7.1.5.2. Offline
13.7.1.5.2.1. Supermarket
13.7.1.5.2.2. Hypermarket
13.7.1.5.2.3. Convenience
Stores
13.7.1.5.2.4. Pharmacies
and Retail Stores
13.7.1.5.2.5. Others
13.7.2. Canada
13.7.2.1. Canada
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
13.7.2.1.1. Fruit
Based
13.7.2.1.2. Dairy
Based
13.7.2.2. Canada
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
13.7.2.2.1. Yogurt
13.7.2.2.2. Kefir
13.7.2.2.3. Probugs
13.7.2.2.4. Others
13.7.2.3. Canada
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
13.7.2.3.1. Lactobacillus
casei Immunitas
13.7.2.3.2. L.
casei Shirota
13.7.2.3.3. Lactobacillus
johnsonii
13.7.2.3.4. Lactobacillus
helveticus
13.7.2.3.5. Lactobacillus
reuteri MM53
13.7.2.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
13.7.2.3.7. Others
13.7.2.4. Canada
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
13.7.2.4.1. Alleviation
of lactose-intolerance symptoms
13.7.2.4.2. Treatment
of viral and antibiotic-associated diarrhea
13.7.2.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
13.7.2.4.4. Alleviation
of atopic dermatitis symptoms in children
13.7.2.4.5. Prevention
of the risk of allergy in infancy
13.7.2.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
13.7.2.4.7. Immune
Response
13.7.2.4.8. Others
13.7.2.5. Canada
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.7.2.5.1. Online
13.7.2.5.2. Offline
13.7.2.5.2.1. Supermarket
13.7.2.5.2.2. Hypermarket
13.7.2.5.2.3. Convenience
Stores
13.7.2.5.2.4. Pharmacies
and Retail Stores
13.7.2.5.2.5. Others
13.7.3. Mexico
13.7.3.1. Mexico
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
13.7.3.1.1. Fruit
Based
13.7.3.1.2. Dairy
Based
13.7.3.2. Mexico
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
13.7.3.2.1. Yogurt
13.7.3.2.2. Kefir
13.7.3.2.3. Probugs
13.7.3.2.4. Others
13.7.3.3. Mexico
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
13.7.3.3.1. Lactobacillus
casei Immunitas
13.7.3.3.2. L.
casei Shirota
13.7.3.3.3. Lactobacillus
johnsonii
13.7.3.3.4. Lactobacillus
helveticus
13.7.3.3.5. Lactobacillus
reuteri MM53
13.7.3.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
13.7.3.3.7. Others
13.7.3.4. Mexico
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
13.7.3.4.1. Alleviation
of lactose-intolerance symptoms
13.7.3.4.2. Treatment
of viral and antibiotic-associated diarrhea
13.7.3.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
13.7.3.4.4. Alleviation
of atopic dermatitis symptoms in children
13.7.3.4.5. Prevention
of the risk of allergy in infancy
13.7.3.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
13.7.3.4.7. Immune
Response
13.7.3.4.8. Others
13.7.3.5. Mexico
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.7.3.5.1. Online
13.7.3.5.2. Offline
13.7.3.5.2.1. Supermarket
13.7.3.5.2.2. Hypermarket
13.7.3.5.2.3. Convenience
Stores
13.7.3.5.2.4. Pharmacies
and Retail Stores
13.7.3.5.2.5. Others
13.7.4. Rest of
North America
13.7.4.1. Rest
of North America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Type
13.7.4.1.1. Fruit
Based
13.7.4.1.2. Dairy
Based
13.7.4.2. Rest
of North America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Product
13.7.4.2.1. Yogurt
13.7.4.2.2. Kefir
13.7.4.2.3. Probugs
13.7.4.2.4. Others
13.7.4.3. Rest
of North America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Strains
13.7.4.3.1. Lactobacillus
casei Immunitas
13.7.4.3.2. L.
casei Shirota
13.7.4.3.3. Lactobacillus
johnsonii
13.7.4.3.4. Lactobacillus
helveticus
13.7.4.3.5. Lactobacillus
reuteri MM53
13.7.4.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
13.7.4.3.7. Others
13.7.4.4. Rest
of North America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Indication
13.7.4.4.1. Alleviation
of lactose-intolerance symptoms
13.7.4.4.2. Treatment
of viral and antibiotic-associated diarrhea
13.7.4.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
13.7.4.4.4. Alleviation
of atopic dermatitis symptoms in children
13.7.4.4.5. Prevention
of the risk of allergy in infancy
13.7.4.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
13.7.4.4.7. Immune
Response
13.7.4.4.8. Others
13.7.4.5. Rest
of North America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
13.7.4.5.1. Online
13.7.4.5.2. Offline
13.7.4.5.2.1. Supermarket
13.7.4.5.2.2. Hypermarket
13.7.4.5.2.3. Convenience
Stores
13.7.4.5.2.4. Pharmacies
and Retail Stores
13.7.4.5.2.5. Others
13.8. Key
Segment for Channeling Investments
13.8.1. By
Country
13.8.2. By Type
13.8.3. By
Product
13.8.4. By
Strains
13.8.5. By
Indication
13.8.6. By
Distribution Channel
14. Europe
Probiotic Beverage Market Analysis and Forecasts, 2020 - 2028
14.1. Overview
14.1.1. Europe
Probiotic Beverage Market Revenue (US$ Mn)
14.2. Europe
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
14.2.1. Fruit
Based
14.2.2. Dairy
Based
14.3. Europe
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
14.3.1. Yogurt
14.3.2. Kefir
14.3.3. Probugs
14.3.4. Others
14.4. Europe
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
14.4.1. Lactobacillus
casei Immunitas
14.4.2. L.
casei Shirota
14.4.3. Lactobacillus
johnsonii
14.4.4. Lactobacillus
helveticus
14.4.5. Lactobacillus
reuteri MM53
14.4.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
14.4.7. Others
14.5. Europe
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
14.5.1. Alleviation
of lactose-intolerance symptoms
14.5.2. Treatment
of viral and antibiotic-associated diarrhea
14.5.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
14.5.4. Alleviation
of atopic dermatitis symptoms in children
14.5.5. Prevention
of the risk of allergy in infancy
14.5.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
14.5.7. Immune
Response
14.5.8. Others
14.6. Europe
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.6.1. Online
14.6.2. Offline
14.6.2.1. Supermarket
14.6.2.2. Hypermarket
14.6.2.3. Convenience
Stores
14.6.2.4. Pharmacies
and Retail Stores
14.6.2.5. Others
14.7. Europe
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Country
14.7.1. France
14.7.1.1. France
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
14.7.1.1.1. Fruit
Based
14.7.1.1.2. Dairy
Based
14.7.1.2. France
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
14.7.1.2.1. Yogurt
14.7.1.2.2. Kefir
14.7.1.2.3. Probugs
14.7.1.2.4. Others
14.7.1.3. France
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
14.7.1.3.1. Lactobacillus
casei Immunitas
14.7.1.3.2. L.
casei Shirota
14.7.1.3.3. Lactobacillus
johnsonii
14.7.1.3.4. Lactobacillus
helveticus
14.7.1.3.5. Lactobacillus
reuteri MM53
14.7.1.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
14.7.1.3.7. Others
14.7.1.4. France
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
14.7.1.4.1. Alleviation
of lactose-intolerance symptoms
14.7.1.4.2. Treatment
of viral and antibiotic-associated diarrhea
14.7.1.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
14.7.1.4.4. Alleviation
of atopic dermatitis symptoms in children
14.7.1.4.5. Prevention
of the risk of allergy in infancy
14.7.1.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
14.7.1.4.7. Immune
Response
14.7.1.4.8. Others
14.7.1.5. France
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.1.5.1. Online
14.7.1.5.2. Offline
14.7.1.5.2.1. Supermarket
14.7.1.5.2.2. Hypermarket
14.7.1.5.2.3. Convenience
Stores
14.7.1.5.2.4. Pharmacies
and Retail Stores
14.7.1.5.2.5. Others
14.7.2. The UK
14.7.2.1. The
UK Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
14.7.2.1.1. Fruit
Based
14.7.2.1.2. Dairy
Based
14.7.2.2. The
UK Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
14.7.2.2.1. Yogurt
14.7.2.2.2. Kefir
14.7.2.2.3. Probugs
14.7.2.2.4. Others
14.7.2.3. The
UK Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
14.7.2.3.1. Lactobacillus
casei Immunitas
14.7.2.3.2. L.
casei Shirota
14.7.2.3.3. Lactobacillus
johnsonii
14.7.2.3.4. Lactobacillus
helveticus
14.7.2.3.5. Lactobacillus
reuteri MM53
14.7.2.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
14.7.2.3.7. Others
14.7.2.4. The
UK Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
14.7.2.4.1. Alleviation
of lactose-intolerance symptoms
14.7.2.4.2. Treatment
of viral and antibiotic-associated diarrhea
14.7.2.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
14.7.2.4.4. Alleviation
of atopic dermatitis symptoms in children
14.7.2.4.5. Prevention
of the risk of allergy in infancy
14.7.2.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
14.7.2.4.7. Immune
Response
14.7.2.4.8. Others
14.7.2.5. The
UK Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.2.5.1. Online
14.7.2.5.2. Offline
14.7.2.5.2.1. Supermarket
14.7.2.5.2.2. Hypermarket
14.7.2.5.2.3. Convenience
Stores
14.7.2.5.2.4. Pharmacies
and Retail Stores
14.7.2.5.2.5. Others
14.7.3. Spain
14.7.3.1. Spain
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
14.7.3.1.1. Fruit
Based
14.7.3.1.2. Dairy
Based
14.7.3.2. Spain
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
14.7.3.2.1. Yogurt
14.7.3.2.2. Kefir
14.7.3.2.3. Probugs
14.7.3.2.4. Others
14.7.3.3. Spain
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
14.7.3.3.1. Lactobacillus
casei Immunitas
14.7.3.3.2. L.
casei Shirota
14.7.3.3.3. Lactobacillus
johnsonii
14.7.3.3.4. Lactobacillus
helveticus
14.7.3.3.5. Lactobacillus
reuteri MM53
14.7.3.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
14.7.3.3.7. Others
14.7.3.4. Spain
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
14.7.3.4.1. Alleviation
of lactose-intolerance symptoms
14.7.3.4.2. Treatment
of viral and antibiotic-associated diarrhea
14.7.3.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
14.7.3.4.4. Alleviation
of atopic dermatitis symptoms in children
14.7.3.4.5. Prevention
of the risk of allergy in infancy
14.7.3.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
14.7.3.4.7. Immune
Response
14.7.3.4.8. Others
14.7.3.5. Spain
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.3.5.1. Online
14.7.3.5.2. Offline
14.7.3.5.2.1. Supermarket
14.7.3.5.2.2. Hypermarket
14.7.3.5.2.3. Convenience
Stores
14.7.3.5.2.4. Pharmacies
and Retail Stores
14.7.3.5.2.5. Others
14.7.4. Germany
14.7.4.1. Germany
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
14.7.4.1.1. Fruit
Based
14.7.4.1.2. Dairy
Based
14.7.4.2. Germany
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
14.7.4.2.1. Yogurt
14.7.4.2.2. Kefir
14.7.4.2.3. Probugs
14.7.4.2.4. Others
14.7.4.3. Germany
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
14.7.4.3.1. Lactobacillus
casei Immunitas
14.7.4.3.2. L.
casei Shirota
14.7.4.3.3. Lactobacillus
johnsonii
14.7.4.3.4. Lactobacillus
helveticus
14.7.4.3.5. Lactobacillus
reuteri MM53
14.7.4.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
14.7.4.3.7. Others
14.7.4.4. Germany
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
14.7.4.4.1. Alleviation
of lactose-intolerance symptoms
14.7.4.4.2. Treatment
of viral and antibiotic-associated diarrhea
14.7.4.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
14.7.4.4.4. Alleviation
of atopic dermatitis symptoms in children
14.7.4.4.5. Prevention
of the risk of allergy in infancy
14.7.4.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
14.7.4.4.7. Immune
Response
14.7.4.4.8. Others
14.7.4.5. Germany
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.7.4.5.1. Online
14.7.4.5.2. Offline
14.7.4.5.2.1. Supermarket
14.7.4.5.2.2. Hypermarket
14.7.4.5.2.3. Convenience
Stores
14.7.4.5.2.4. Pharmacies
and Retail Stores
14.7.4.5.2.5. Others
14.7.5. Italy
14.7.5.1. Italy
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
14.7.5.1.1. Fruit
Based
14.7.5.1.2. Dairy
Based
14.7.5.2. Italy
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
14.7.5.2.1. Yogurt
14.7.5.2.2. Kefir
14.7.5.2.3. Probugs
14.7.5.2.4. Others
14.7.5.3. Italy
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
14.7.5.3.1. Lactobacillus
casei Immunitas
14.7.5.3.2. L.
casei Shirota
14.7.5.3.3. Lactobacillus
johnsonii
14.7.5.3.4. Lactobacillus
helveticus
14.7.5.3.5. Lactobacillus
reuteri MM53
14.7.5.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
14.7.5.3.7. Others
14.7.5.4. Italy
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
14.7.5.4.1. Alleviation
of lactose-intolerance symptoms
14.7.5.4.2. Treatment
of viral and antibiotic-associated diarrhea
14.7.5.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
14.7.5.4.4. Alleviation
of atopic dermatitis symptoms in children
14.7.5.4.5. Prevention
of the risk of allergy in infancy
14.7.5.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
14.7.5.4.7. Immune
Response
14.7.5.4.8. Others
14.7.5.5. Italy
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.5.5.1. Online
14.7.5.5.2. Offline
14.7.5.5.2.1. Supermarket
14.7.5.5.2.2. Hypermarket
14.7.5.5.2.3. Convenience
Stores
14.7.5.5.2.4. Pharmacies
and Retail Stores
14.7.5.5.2.5. Others
14.7.6. Nordic
Countries
14.7.6.1. Nordic
Countries Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
14.7.6.1.1. Fruit
Based
14.7.6.1.2. Dairy
Based
14.7.6.2. Nordic
Countries Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
14.7.6.2.1. Yogurt
14.7.6.2.2. Kefir
14.7.6.2.3. Probugs
14.7.6.2.4. Others
14.7.6.3. Nordic
Countries Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
14.7.6.3.1. Lactobacillus
casei Immunitas
14.7.6.3.2. L.
casei Shirota
14.7.6.3.3. Lactobacillus
johnsonii
14.7.6.3.4. Lactobacillus
helveticus
14.7.6.3.5. Lactobacillus
reuteri MM53
14.7.6.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
14.7.6.3.7. Others
14.7.6.4. Nordic
Countries Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Indication
14.7.6.4.1. Alleviation
of lactose-intolerance symptoms
14.7.6.4.2. Treatment
of viral and antibiotic-associated diarrhea
14.7.6.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
14.7.6.4.4. Alleviation
of atopic dermatitis symptoms in children
14.7.6.4.5. Prevention
of the risk of allergy in infancy
14.7.6.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
14.7.6.4.7. Immune
Response
14.7.6.4.8. Others
14.7.6.5. Nordic
Countries Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.7.6.5.1. Online
14.7.6.5.2. Offline
14.7.6.5.2.1. Supermarket
14.7.6.5.2.2. Hypermarket
14.7.6.5.2.3. Convenience
Stores
14.7.6.5.2.4. Pharmacies
and Retail Stores
14.7.6.5.2.5. Others
14.7.6.6. Nordic
Countries Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Country
14.7.6.6.1. Denmark
14.7.6.6.2. Finland
14.7.6.6.3. Iceland
14.7.6.6.4. Sweden
14.7.6.6.5. Norway
14.7.7. Benelux
Union
14.7.7.1. Benelux
Union Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
14.7.7.1.1. Fruit
Based
14.7.7.1.2. Dairy
Based
14.7.7.2. Benelux
Union Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
14.7.7.2.1. Yogurt
14.7.7.2.2. Kefir
14.7.7.2.3. Probugs
14.7.7.2.4. Others
14.7.7.3. Benelux
Union Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
14.7.7.3.1. Lactobacillus
casei Immunitas
14.7.7.3.2. L.
casei Shirota
14.7.7.3.3. Lactobacillus
johnsonii
14.7.7.3.4. Lactobacillus
helveticus
14.7.7.3.5. Lactobacillus
reuteri MM53
14.7.7.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
14.7.7.3.7. Others
14.7.7.4. Benelux
Union Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
14.7.7.4.1. Alleviation
of lactose-intolerance symptoms
14.7.7.4.2. Treatment
of viral and antibiotic-associated diarrhea
14.7.7.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
14.7.7.4.4. Alleviation
of atopic dermatitis symptoms in children
14.7.7.4.5. Prevention
of the risk of allergy in infancy
14.7.7.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
14.7.7.4.7. Immune
Response
14.7.7.4.8. Others
14.7.7.5. Benelux
Union Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.7.5.1. Online
14.7.7.5.2. Offline
14.7.7.5.2.1. Supermarket
14.7.7.5.2.2. Hypermarket
14.7.7.5.2.3. Convenience
Stores
14.7.7.5.2.4. Pharmacies
and Retail Stores
14.7.7.5.2.5. Others
14.7.7.6. Benelux
Union Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Country
14.7.7.6.1. Belgium
14.7.7.6.2. The
Netherlands
14.7.7.6.3. Luxembourg
14.7.8. Rest of
Europe
14.7.8.1. Rest
of Europe Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
14.7.8.1.1. Fruit
Based
14.7.8.1.2. Dairy
Based
14.7.8.2. Rest
of Europe Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
14.7.8.2.1. Yogurt
14.7.8.2.2. Kefir
14.7.8.2.3. Probugs
14.7.8.2.4. Others
14.7.8.3. Rest
of Europe Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
14.7.8.3.1. Lactobacillus
casei Immunitas
14.7.8.3.2. L.
casei Shirota
14.7.8.3.3. Lactobacillus
johnsonii
14.7.8.3.4. Lactobacillus
helveticus
14.7.8.3.5. Lactobacillus
reuteri MM53
14.7.8.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
14.7.8.3.7. Others
14.7.8.4. Rest
of Europe Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Indication
14.7.8.4.1. Alleviation
of lactose-intolerance symptoms
14.7.8.4.2. Treatment
of viral and antibiotic-associated diarrhea
14.7.8.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
14.7.8.4.4. Alleviation
of atopic dermatitis symptoms in children
14.7.8.4.5. Prevention
of the risk of allergy in infancy
14.7.8.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
14.7.8.4.7. Immune
Response
14.7.8.4.8. Others
14.7.8.5. Rest
of Europe Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.8.5.1. Online
14.7.8.5.2. Offline
14.7.8.5.2.1. Supermarket
14.7.8.5.2.2. Hypermarket
14.7.8.5.2.3. Convenience
Stores
14.7.8.5.2.4. Pharmacies
and Retail Stores
14.7.8.5.2.5. Others
14.8. Key
Segment for Channeling Investments
14.8.1. By
Country
14.8.2. By Type
14.8.3. By
Product
14.8.4. By
Strains
14.8.5. By
Indication
14.8.6. By
Distribution Channel
15. Asia
Pacific Probiotic Beverage Market Analysis and Forecasts, 2020 - 2028
15.1. Overview
15.1.1. Asia
Pacific Probiotic Beverage Market Revenue (US$ Mn)
15.2. Asia
Pacific Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
15.2.1. Fruit
Based
15.2.2. Dairy
Based
15.3. Asia
Pacific Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
15.3.1. Yogurt
15.3.2. Kefir
15.3.3. Probugs
15.3.4. Others
15.4. Asia
Pacific Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
15.4.1. Lactobacillus
casei Immunitas
15.4.2. L.
casei Shirota
15.4.3. Lactobacillus
johnsonii
15.4.4. Lactobacillus
helveticus
15.4.5. Lactobacillus
reuteri MM53
15.4.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
15.4.7. Others
15.5. Asia
Pacific Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
15.5.1. Alleviation
of lactose-intolerance symptoms
15.5.2. Treatment
of viral and antibiotic-associated diarrhea
15.5.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
15.5.4. Alleviation
of atopic dermatitis symptoms in children
15.5.5. Prevention
of the risk of allergy in infancy
15.5.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
15.5.7. Immune
Response
15.5.8. Others
15.6. Asia
Pacific Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.6.1. Online
15.6.2. Offline
15.6.2.1. Supermarket
15.6.2.2. Hypermarket
15.6.2.3. Convenience
Stores
15.6.2.4. Pharmacies
and Retail Stores
15.6.2.5. Others
15.7. Asia
Pacific Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Country
15.7.1. China
15.7.1.1. China
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
15.7.1.1.1. Fruit
Based
15.7.1.1.2. Dairy
Based
15.7.1.2. China
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
15.7.1.2.1. Yogurt
15.7.1.2.2. Kefir
15.7.1.2.3. Probugs
15.7.1.2.4. Others
15.7.1.3. China
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
15.7.1.3.1. Lactobacillus
casei Immunitas
15.7.1.3.2. L.
casei Shirota
15.7.1.3.3. Lactobacillus
johnsonii
15.7.1.3.4. Lactobacillus
helveticus
15.7.1.3.5. Lactobacillus
reuteri MM53
15.7.1.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
15.7.1.3.7. Others
15.7.1.4. China
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
15.7.1.4.1. Alleviation
of lactose-intolerance symptoms
15.7.1.4.2. Treatment
of viral and antibiotic-associated diarrhea
15.7.1.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
15.7.1.4.4. Alleviation
of atopic dermatitis symptoms in children
15.7.1.4.5. Prevention
of the risk of allergy in infancy
15.7.1.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
15.7.1.4.7. Immune
Response
15.7.1.4.8. Others
15.7.1.5. China
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.7.1.5.1. Online
15.7.1.5.2. Offline
15.7.1.5.2.1. Supermarket
15.7.1.5.2.2. Hypermarket
15.7.1.5.2.3. Convenience
Stores
15.7.1.5.2.4. Pharmacies
and Retail Stores
15.7.1.5.2.5. Others
15.7.2. Japan
15.7.2.1. Japan
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
15.7.2.1.1. Fruit
Based
15.7.2.1.2. Dairy
Based
15.7.2.2. Japan
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
15.7.2.2.1. Yogurt
15.7.2.2.2. Kefir
15.7.2.2.3. Probugs
15.7.2.2.4. Others
15.7.2.3. Japan
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
15.7.2.3.1. Lactobacillus
casei Immunitas
15.7.2.3.2. L.
casei Shirota
15.7.2.3.3. Lactobacillus
johnsonii
15.7.2.3.4. Lactobacillus
helveticus
15.7.2.3.5. Lactobacillus
reuteri MM53
15.7.2.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
15.7.2.3.7. Others
15.7.2.4. Japan
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
15.7.2.4.1. Alleviation
of lactose-intolerance symptoms
15.7.2.4.2. Treatment
of viral and antibiotic-associated diarrhea
15.7.2.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
15.7.2.4.4. Alleviation
of atopic dermatitis symptoms in children
15.7.2.4.5. Prevention
of the risk of allergy in infancy
15.7.2.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
15.7.2.4.7. Immune
Response
15.7.2.4.8. Others
15.7.2.5. Japan
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.7.2.5.1. Online
15.7.2.5.2. Offline
15.7.2.5.2.1. Supermarket
15.7.2.5.2.2. Hypermarket
15.7.2.5.2.3. Convenience
Stores
15.7.2.5.2.4. Pharmacies
and Retail Stores
15.7.2.5.2.5. Others
15.7.3. India
15.7.3.1. India
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
15.7.3.1.1. Fruit
Based
15.7.3.1.2. Dairy
Based
15.7.3.2. India
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
15.7.3.2.1. Yogurt
15.7.3.2.2. Kefir
15.7.3.2.3. Probugs
15.7.3.2.4. Others
15.7.3.3. India
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
15.7.3.3.1. Lactobacillus
casei Immunitas
15.7.3.3.2. L.
casei Shirota
15.7.3.3.3. Lactobacillus
johnsonii
15.7.3.3.4. Lactobacillus
helveticus
15.7.3.3.5. Lactobacillus
reuteri MM53
15.7.3.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
15.7.3.3.7. Others
15.7.3.4. India
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
15.7.3.4.1. Alleviation
of lactose-intolerance symptoms
15.7.3.4.2. Treatment
of viral and antibiotic-associated diarrhea
15.7.3.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
15.7.3.4.4. Alleviation
of atopic dermatitis symptoms in children
15.7.3.4.5. Prevention
of the risk of allergy in infancy
15.7.3.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
15.7.3.4.7. Immune
Response
15.7.3.4.8. Others
15.7.3.5. India
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.7.3.5.1. Online
15.7.3.5.2. Offline
15.7.3.5.2.1. Supermarket
15.7.3.5.2.2. Hypermarket
15.7.3.5.2.3. Convenience
Stores
15.7.3.5.2.4. Pharmacies
and Retail Stores
15.7.3.5.2.5. Others
15.7.4. New
Zealand
15.7.4.1. New
Zealand Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
15.7.4.1.1. Fruit
Based
15.7.4.1.2. Dairy
Based
15.7.4.2. New
Zealand Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
15.7.4.2.1. Yogurt
15.7.4.2.2. Kefir
15.7.4.2.3. Probugs
15.7.4.2.4. Others
15.7.4.3. New
Zealand Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
15.7.4.3.1. Lactobacillus
casei Immunitas
15.7.4.3.2. L.
casei Shirota
15.7.4.3.3. Lactobacillus
johnsonii
15.7.4.3.4. Lactobacillus
helveticus
15.7.4.3.5. Lactobacillus
reuteri MM53
15.7.4.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
15.7.4.3.7. Others
15.7.4.4. New
Zealand Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
15.7.4.4.1. Alleviation
of lactose-intolerance symptoms
15.7.4.4.2. Treatment
of viral and antibiotic-associated diarrhea
15.7.4.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
15.7.4.4.4. Alleviation
of atopic dermatitis symptoms in children
15.7.4.4.5. Prevention
of the risk of allergy in infancy
15.7.4.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
15.7.4.4.7. Immune
Response
15.7.4.4.8. Others
15.7.4.5. New
Zealand Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.4.5.1. Online
15.7.4.5.2. Offline
15.7.4.5.2.1. Supermarket
15.7.4.5.2.2. Hypermarket
15.7.4.5.2.3. Convenience
Stores
15.7.4.5.2.4. Pharmacies
and Retail Stores
15.7.4.5.2.5. Others
15.7.5. Australia
15.7.5.1. Australia
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
15.7.5.1.1. Fruit
Based
15.7.5.1.2. Dairy
Based
15.7.5.2. Australia
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
15.7.5.2.1. Yogurt
15.7.5.2.2. Kefir
15.7.5.2.3. Probugs
15.7.5.2.4. Others
15.7.5.3. Australia
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
15.7.5.3.1. Lactobacillus
casei Immunitas
15.7.5.3.2. L.
casei Shirota
15.7.5.3.3. Lactobacillus
johnsonii
15.7.5.3.4. Lactobacillus
helveticus
15.7.5.3.5. Lactobacillus
reuteri MM53
15.7.5.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
15.7.5.3.7. Others
15.7.5.4. Australia
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
15.7.5.4.1. Alleviation
of lactose-intolerance symptoms
15.7.5.4.2. Treatment
of viral and antibiotic-associated diarrhea
15.7.5.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
15.7.5.4.4. Alleviation
of atopic dermatitis symptoms in children
15.7.5.4.5. Prevention
of the risk of allergy in infancy
15.7.5.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
15.7.5.4.7. Immune
Response
15.7.5.4.8. Others
15.7.5.5. Australia
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.7.5.5.1. Online
15.7.5.5.2. Offline
15.7.5.5.2.1. Supermarket
15.7.5.5.2.2. Hypermarket
15.7.5.5.2.3. Convenience
Stores
15.7.5.5.2.4. Pharmacies
and Retail Stores
15.7.5.5.2.5. Others
15.7.6. South
Korea
15.7.6.1. South
Korea Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
15.7.6.1.1. Fruit
Based
15.7.6.1.2. Dairy
Based
15.7.6.2. South
Korea Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
15.7.6.2.1. Yogurt
15.7.6.2.2. Kefir
15.7.6.2.3. Probugs
15.7.6.2.4. Others
15.7.6.3. South
Korea Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
15.7.6.3.1. Lactobacillus
casei Immunitas
15.7.6.3.2. L.
casei Shirota
15.7.6.3.3. Lactobacillus
johnsonii
15.7.6.3.4. Lactobacillus
helveticus
15.7.6.3.5. Lactobacillus
reuteri MM53
15.7.6.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
15.7.6.3.7. Others
15.7.6.4. South
Korea Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
15.7.6.4.1. Alleviation
of lactose-intolerance symptoms
15.7.6.4.2. Treatment
of viral and antibiotic-associated diarrhea
15.7.6.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
15.7.6.4.4. Alleviation
of atopic dermatitis symptoms in children
15.7.6.4.5. Prevention
of the risk of allergy in infancy
15.7.6.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
15.7.6.4.7. Immune
Response
15.7.6.4.8. Others
15.7.6.5. South
Korea Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.7.6.5.1. Online
15.7.6.5.2. Offline
15.7.6.5.2.1. Supermarket
15.7.6.5.2.2. Hypermarket
15.7.6.5.2.3. Convenience
Stores
15.7.6.5.2.4. Pharmacies
and Retail Stores
15.7.6.5.2.5. Others
15.7.7. Southeast
Asia
15.7.7.1. Southeast
Asia Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
15.7.7.1.1. Fruit
Based
15.7.7.1.2. Dairy
Based
15.7.7.2. Southeast
Asia Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
15.7.7.2.1. Yogurt
15.7.7.2.2. Kefir
15.7.7.2.3. Probugs
15.7.7.2.4. Others
15.7.7.3. Southeast
Asia Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
15.7.7.3.1. Lactobacillus
casei Immunitas
15.7.7.3.2. L.
casei Shirota
15.7.7.3.3. Lactobacillus
johnsonii
15.7.7.3.4. Lactobacillus
helveticus
15.7.7.3.5. Lactobacillus
reuteri MM53
15.7.7.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
15.7.7.3.7. Others
15.7.7.4. Southeast
Asia Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
15.7.7.4.1. Alleviation
of lactose-intolerance symptoms
15.7.7.4.2. Treatment
of viral and antibiotic-associated diarrhea
15.7.7.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
15.7.7.4.4. Alleviation
of atopic dermatitis symptoms in children
15.7.7.4.5. Prevention
of the risk of allergy in infancy
15.7.7.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
15.7.7.4.7. Immune
Response
15.7.7.4.8. Others
15.7.7.5. Southeast
Asia Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.7.7.5.1. Online
15.7.7.5.2. Offline
15.7.7.5.2.1. Supermarket
15.7.7.5.2.2. Hypermarket
15.7.7.5.2.3. Convenience
Stores
15.7.7.5.2.4. Pharmacies
and Retail Stores
15.7.7.5.2.5. Others
15.7.7.6. Southeast
Asia Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Country
15.7.7.6.1. Indonesia
15.7.7.6.2. Thailand
15.7.7.6.3. Malaysia
15.7.7.6.4. Singapore
15.7.7.6.5. Rest
of Southeast Asia
15.7.8. Rest of
Asia Pacific
15.7.8.1. Rest
of Asia Pacific Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Type
15.7.8.1.1. Fruit
Based
15.7.8.1.2. Dairy
Based
15.7.8.2. Rest
of Asia Pacific Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Product
15.7.8.2.1. Yogurt
15.7.8.2.2. Kefir
15.7.8.2.3. Probugs
15.7.8.2.4. Others
15.7.8.3. Rest
of Asia Pacific Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Strains
15.7.8.3.1. Lactobacillus
casei Immunitas
15.7.8.3.2. L.
casei Shirota
15.7.8.3.3. Lactobacillus
johnsonii
15.7.8.3.4. Lactobacillus
helveticus
15.7.8.3.5. Lactobacillus
reuteri MM53
15.7.8.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
15.7.8.3.7. Others
15.7.8.4. Rest
of Asia Pacific Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Indication
15.7.8.4.1. Alleviation
of lactose-intolerance symptoms
15.7.8.4.2. Treatment
of viral and antibiotic-associated diarrhea
15.7.8.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
15.7.8.4.4. Alleviation
of atopic dermatitis symptoms in children
15.7.8.4.5. Prevention
of the risk of allergy in infancy
15.7.8.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
15.7.8.4.7. Immune
Response
15.7.8.4.8. Others
15.7.8.5. Rest
of Asia Pacific Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.8.5.1. Online
15.7.8.5.2. Offline
15.7.8.5.2.1. Supermarket
15.7.8.5.2.2. Hypermarket
15.7.8.5.2.3. Convenience
Stores
15.7.8.5.2.4. Pharmacies
and Retail Stores
15.7.8.5.2.5. Others
15.8. Key
Segment for Channeling Investments
15.8.1. By
Country
15.8.2. By Type
15.8.3. By
Product
15.8.4. By
Strains
15.8.5. By
Indication
15.8.6. By
Distribution Channel
16. Middle East
and Africa Probiotic Beverage Market Analysis and Forecasts, 2020 - 2028
16.1. Overview
16.1.1. Middle
East and Africa Probiotic Beverage Market Revenue (US$ Mn)
16.2. Middle
East and Africa Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Type
16.2.1. Fruit
Based
16.2.2. Dairy
Based
16.3. Middle
East and Africa Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Product
16.3.1. Yogurt
16.3.2. Kefir
16.3.3. Probugs
16.3.4. Others
16.4. Middle
East and Africa Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Strains
16.4.1. Lactobacillus
casei Immunitas
16.4.2. L.
casei Shirota
16.4.3. Lactobacillus
johnsonii
16.4.4. Lactobacillus
helveticus
16.4.5. Lactobacillus
reuteri MM53
16.4.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
16.4.7. Others
16.5. Middle
East and Africa Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Indication
16.5.1. Alleviation
of lactose-intolerance symptoms
16.5.2. Treatment
of viral and antibiotic-associated diarrhea
16.5.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
16.5.4. Alleviation
of atopic dermatitis symptoms in children
16.5.5. Prevention
of the risk of allergy in infancy
16.5.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
16.5.7. Immune
Response
16.5.8. Others
16.6. Middle
East and Africa Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.6.1. Online
16.6.2. Offline
16.6.2.1. Supermarket
16.6.2.2. Hypermarket
16.6.2.3. Convenience
Stores
16.6.2.4. Pharmacies
and Retail Stores
16.6.2.5. Others
16.7. Middle
East and Africa Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Country
16.7.1. Saudi
Arabia
16.7.1.1. Saudi
Arabia Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
16.7.1.1.1. Fruit
Based
16.7.1.1.2. Dairy
Based
16.7.1.2. Saudi
Arabia Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
16.7.1.2.1. Yogurt
16.7.1.2.2. Kefir
16.7.1.2.3. Probugs
16.7.1.2.4. Others
16.7.1.3. Saudi
Arabia Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
16.7.1.3.1. Lactobacillus
casei Immunitas
16.7.1.3.2. L.
casei Shirota
16.7.1.3.3. Lactobacillus
johnsonii
16.7.1.3.4. Lactobacillus
helveticus
16.7.1.3.5. Lactobacillus
reuteri MM53
16.7.1.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
16.7.1.3.7. Others
16.7.1.4. Saudi
Arabia Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
16.7.1.4.1. Alleviation
of lactose-intolerance symptoms
16.7.1.4.2. Treatment
of viral and antibiotic-associated diarrhea
16.7.1.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
16.7.1.4.4. Alleviation
of atopic dermatitis symptoms in children
16.7.1.4.5. Prevention
of the risk of allergy in infancy
16.7.1.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
16.7.1.4.7. Immune
Response
16.7.1.4.8. Others
16.7.1.5. Saudi
Arabia Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.7.1.5.1. Online
16.7.1.5.2. Offline
16.7.1.5.2.1. Supermarket
16.7.1.5.2.2. Hypermarket
16.7.1.5.2.3. Convenience
Stores
16.7.1.5.2.4. Pharmacies
and Retail Stores
16.7.1.5.2.5. Others
16.7.2. UAE
16.7.2.1. UAE
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
16.7.2.1.1. Fruit
Based
16.7.2.1.2. Dairy
Based
16.7.2.2. UAE
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
16.7.2.2.1. Yogurt
16.7.2.2.2. Kefir
16.7.2.2.3. Probugs
16.7.2.2.4. Others
16.7.2.3. UAE
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
16.7.2.3.1. Lactobacillus
casei Immunitas
16.7.2.3.2. L.
casei Shirota
16.7.2.3.3. Lactobacillus
johnsonii
16.7.2.3.4. Lactobacillus
helveticus
16.7.2.3.5. Lactobacillus
reuteri MM53
16.7.2.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
16.7.2.3.7. Others
16.7.2.4. UAE
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
16.7.2.4.1. Alleviation
of lactose-intolerance symptoms
16.7.2.4.2. Treatment
of viral and antibiotic-associated diarrhea
16.7.2.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
16.7.2.4.4. Alleviation
of atopic dermatitis symptoms in children
16.7.2.4.5. Prevention
of the risk of allergy in infancy
16.7.2.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
16.7.2.4.7. Immune
Response
16.7.2.4.8. Others
16.7.2.5. UAE
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
16.7.2.5.1. Online
16.7.2.5.2. Offline
16.7.2.5.2.1. Supermarket
16.7.2.5.2.2. Hypermarket
16.7.2.5.2.3. Convenience
Stores
16.7.2.5.2.4. Pharmacies
and Retail Stores
16.7.2.5.2.5. Others
16.7.3. Egypt
16.7.3.1. Egypt
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
16.7.3.1.1. Fruit
Based
16.7.3.1.2. Dairy
Based
16.7.3.2. Egypt
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
16.7.3.2.1. Yogurt
16.7.3.2.2. Kefir
16.7.3.2.3. Probugs
16.7.3.2.4. Others
16.7.3.3. Egypt
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
16.7.3.3.1. Lactobacillus
casei Immunitas
16.7.3.3.2. L.
casei Shirota
16.7.3.3.3. Lactobacillus
johnsonii
16.7.3.3.4. Lactobacillus
helveticus
16.7.3.3.5. Lactobacillus
reuteri MM53
16.7.3.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
16.7.3.3.7. Others
16.7.3.4. Egypt
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
16.7.3.4.1. Alleviation
of lactose-intolerance symptoms
16.7.3.4.2. Treatment
of viral and antibiotic-associated diarrhea
16.7.3.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
16.7.3.4.4. Alleviation
of atopic dermatitis symptoms in children
16.7.3.4.5. Prevention
of the risk of allergy in infancy
16.7.3.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
16.7.3.4.7. Immune
Response
16.7.3.4.8. Others
16.7.3.5. Egypt
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
16.7.3.5.1. Online
16.7.3.5.2. Offline
16.7.3.5.2.1. Supermarket
16.7.3.5.2.2. Hypermarket
16.7.3.5.2.3. Convenience
Stores
16.7.3.5.2.4. Pharmacies
and Retail Stores
16.7.3.5.2.5. Others
16.7.4. Kuwait
16.7.4.1. Kuwait
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
16.7.4.1.1. Fruit
Based
16.7.4.1.2. Dairy
Based
16.7.4.2. Kuwait
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
16.7.4.2.1. Yogurt
16.7.4.2.2. Kefir
16.7.4.2.3. Probugs
16.7.4.2.4. Others
16.7.4.3. Kuwait
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
16.7.4.3.1. Lactobacillus
casei Immunitas
16.7.4.3.2. L. casei
Shirota
16.7.4.3.3. Lactobacillus
johnsonii
16.7.4.3.4. Lactobacillus
helveticus
16.7.4.3.5. Lactobacillus
reuteri MM53
16.7.4.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
16.7.4.3.7. Others
16.7.4.4. Kuwait
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
16.7.4.4.1. Alleviation
of lactose-intolerance symptoms
16.7.4.4.2. Treatment
of viral and antibiotic-associated diarrhea
16.7.4.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
16.7.4.4.4. Alleviation
of atopic dermatitis symptoms in children
16.7.4.4.5. Prevention
of the risk of allergy in infancy
16.7.4.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
16.7.4.4.7. Immune
Response
16.7.4.4.8. Others
16.7.4.5. Kuwait
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
16.7.4.5.1. Online
16.7.4.5.2. Offline
16.7.4.5.2.1. Supermarket
16.7.4.5.2.2. Hypermarket
16.7.4.5.2.3. Convenience
Stores
16.7.4.5.2.4. Pharmacies
and Retail Stores
16.7.4.5.2.5. Others
16.7.5. South
Africa
16.7.5.1. South
Africa Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
16.7.5.1.1. Fruit
Based
16.7.5.1.2. Dairy
Based
16.7.5.2. South
Africa Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
16.7.5.2.1. Yogurt
16.7.5.2.2. Kefir
16.7.5.2.3. Probugs
16.7.5.2.4. Others
16.7.5.3. South
Africa Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
16.7.5.3.1. Lactobacillus
casei Immunitas
16.7.5.3.2. L.
casei Shirota
16.7.5.3.3. Lactobacillus
johnsonii
16.7.5.3.4. Lactobacillus
helveticus
16.7.5.3.5. Lactobacillus
reuteri MM53
16.7.5.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
16.7.5.3.7. Others
16.7.5.4. South
Africa Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
16.7.5.4.1. Alleviation
of lactose-intolerance symptoms
16.7.5.4.2. Treatment
of viral and antibiotic-associated diarrhea
16.7.5.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
16.7.5.4.4. Alleviation
of atopic dermatitis symptoms in children
16.7.5.4.5. Prevention
of the risk of allergy in infancy
16.7.5.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
16.7.5.4.7. Immune
Response
16.7.5.4.8. Others
16.7.5.5. South
Africa Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.7.5.5.1. Online
16.7.5.5.2. Offline
16.7.5.5.2.1. Supermarket
16.7.5.5.2.2. Hypermarket
16.7.5.5.2.3. Convenience
Stores
16.7.5.5.2.4. Pharmacies
and Retail Stores
16.7.5.5.2.5. Others
16.7.6. Rest of
Middle East & Africa
16.7.6.1. Rest
of Middle East & Africa Probiotic Beverage Market Revenue (US$ Mn) and
Forecasts, By Type
16.7.6.1.1. Fruit
Based
16.7.6.1.2. Dairy
Based
16.7.6.2. Rest
of Middle East & Africa Probiotic Beverage Market Revenue (US$ Mn) and
Forecasts, By Product
16.7.6.2.1. Yogurt
16.7.6.2.2. Kefir
16.7.6.2.3. Probugs
16.7.6.2.4. Others
16.7.6.3. Rest
of Middle East & Africa Probiotic Beverage Market Revenue (US$ Mn) and Forecasts,
By Strains
16.7.6.3.1. Lactobacillus
casei Immunitas
16.7.6.3.2. L.
casei Shirota
16.7.6.3.3. Lactobacillus
johnsonii
16.7.6.3.4. Lactobacillus
helveticus
16.7.6.3.5. Lactobacillus
reuteri MM53
16.7.6.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
16.7.6.3.7. Others
16.7.6.4. Rest
of Middle East & Africa Probiotic Beverage Market Revenue (US$ Mn) and
Forecasts, By Indication
16.7.6.4.1. Alleviation
of lactose-intolerance symptoms
16.7.6.4.2. Treatment
of viral and antibiotic-associated diarrhea
16.7.6.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
16.7.6.4.4. Alleviation
of atopic dermatitis symptoms in children
16.7.6.4.5. Prevention
of the risk of allergy in infancy
16.7.6.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
16.7.6.4.7. Immune
Response
16.7.6.4.8. Others
16.7.6.5. Rest
of Middle East & Africa Probiotic Beverage Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.7.6.5.1. Online
16.7.6.5.2. Offline
16.7.6.5.2.1. Supermarket
16.7.6.5.2.2. Hypermarket
16.7.6.5.2.3. Convenience
Stores
16.7.6.5.2.4. Pharmacies
and Retail Stores
16.7.6.5.2.5. Others
16.8. Key
Segment for Channeling Investments
16.8.1. By
Country
16.8.2. By Type
16.8.3. By
Product
16.8.4. By
Strains
16.8.5. By
Indication
16.8.6. By
Distribution Channel
17. Latin
America Probiotic Beverage Market Analysis and Forecasts, 2020 - 2028
17.1. Overview
17.1.1. Latin
America Probiotic Beverage Market Revenue (US$ Mn)
17.2. Latin
America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
17.2.1. Fruit
Based
17.2.2. Dairy
Based
17.3. Latin
America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
17.3.1. Yogurt
17.3.2. Kefir
17.3.3. Probugs
17.3.4. Others
17.4. Latin
America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
17.4.1. Lactobacillus
casei Immunitas
17.4.2. L.
casei Shirota
17.4.3. Lactobacillus
johnsonii
17.4.4. Lactobacillus
helveticus
17.4.5. Lactobacillus
reuteri MM53
17.4.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
17.4.7. Others
17.5. Latin
America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
17.5.1. Alleviation
of lactose-intolerance symptoms
17.5.2. Treatment
of viral and antibiotic-associated diarrhea
17.5.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
17.5.4. Alleviation
of atopic dermatitis symptoms in children
17.5.5. Prevention
of the risk of allergy in infancy
17.5.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
17.5.7. Immune
Response
17.5.8. Others
17.6. Latin
America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
17.6.1. Online
17.6.2. Offline
17.6.2.1. Supermarket
17.6.2.2. Hypermarket
17.6.2.3. Convenience
Stores
17.6.2.4. Pharmacies
and Retail Stores
17.6.2.5. Others
17.7. Latin
America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Country
17.7.1. Brazil
17.7.1.1. Brazil
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
17.7.1.1.1. Fruit
Based
17.7.1.1.2. Dairy
Based
17.7.1.2. Brazil
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
17.7.1.2.1. Yogurt
17.7.1.2.2. Kefir
17.7.1.2.3. Probugs
17.7.1.2.4. Others
17.7.1.3. Brazil
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
17.7.1.3.1. Lactobacillus
casei Immunitas
17.7.1.3.2. L.
casei Shirota
17.7.1.3.3. Lactobacillus
johnsonii
17.7.1.3.4. Lactobacillus
helveticus
17.7.1.3.5. Lactobacillus
reuteri MM53
17.7.1.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
17.7.1.3.7. Others
17.7.1.4. Brazil
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
17.7.1.4.1. Alleviation
of lactose-intolerance symptoms
17.7.1.4.2. Treatment
of viral and antibiotic-associated diarrhea
17.7.1.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
17.7.1.4.4. Alleviation
of atopic dermatitis symptoms in children
17.7.1.4.5. Prevention
of the risk of allergy in infancy
17.7.1.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
17.7.1.4.7. Immune
Response
17.7.1.4.8. Others
17.7.1.5. Brazil
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
17.7.1.5.1. Online
17.7.1.5.2. Offline
17.7.1.5.2.1. Supermarket
17.7.1.5.2.2. Hypermarket
17.7.1.5.2.3. Convenience
Stores
17.7.1.5.2.4. Pharmacies
and Retail Stores
17.7.1.5.2.5. Others
17.7.2. Argentina
17.7.2.1. Argentina
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Type
17.7.2.1.1. Fruit
Based
17.7.2.1.2. Dairy
Based
17.7.2.2. Argentina
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Product
17.7.2.2.1. Yogurt
17.7.2.2.2. Kefir
17.7.2.2.3. Probugs
17.7.2.2.4. Others
17.7.2.3. Argentina
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Strains
17.7.2.3.1. Lactobacillus
casei Immunitas
17.7.2.3.2. L.
casei Shirota
17.7.2.3.3. Lactobacillus
johnsonii
17.7.2.3.4. Lactobacillus
helveticus
17.7.2.3.5. Lactobacillus
reuteri MM53
17.7.2.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
17.7.2.3.7. Others
17.7.2.4. Argentina
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Indication
17.7.2.4.1. Alleviation
of lactose-intolerance symptoms
17.7.2.4.2. Treatment
of viral and antibiotic-associated diarrhea
17.7.2.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
17.7.2.4.4. Alleviation
of atopic dermatitis symptoms in children
17.7.2.4.5. Prevention
of the risk of allergy in infancy
17.7.2.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
17.7.2.4.7. Immune
Response
17.7.2.4.8. Others
17.7.2.5. Argentina
Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
17.7.2.5.1. Online
17.7.2.5.2. Offline
17.7.2.5.2.1. Supermarket
17.7.2.5.2.2. Hypermarket
17.7.2.5.2.3. Convenience
Stores
17.7.2.5.2.4. Pharmacies
and Retail Stores
17.7.2.5.2.5. Others
17.7.3. Rest of
Latin America
17.7.3.1. Rest
of Latin America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Type
17.7.3.1.1. Fruit
Based
17.7.3.1.2. Dairy
Based
17.7.3.2. Rest
of Latin America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Product
17.7.3.2.1. Yogurt
17.7.3.2.2. Kefir
17.7.3.2.3. Probugs
17.7.3.2.4. Others
17.7.3.3. Rest
of Latin America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Strains
17.7.3.3.1. Lactobacillus
casei Immunitas
17.7.3.3.2. L.
casei Shirota
17.7.3.3.3. Lactobacillus
johnsonii
17.7.3.3.4. Lactobacillus
helveticus
17.7.3.3.5. Lactobacillus
reuteri MM53
17.7.3.3.6. Lactobacillus
rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS
17.7.3.3.7. Others
17.7.3.4. Rest
of Latin America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Indication
17.7.3.4.1. Alleviation
of lactose-intolerance symptoms
17.7.3.4.2. Treatment
of viral and antibiotic-associated diarrhea
17.7.3.4.3. Reduction
in symptoms of antibiotic treatment of Helicobacter pylori
17.7.3.4.4. Alleviation
of atopic dermatitis symptoms in children
17.7.3.4.5. Prevention
of the risk of allergy in infancy
17.7.3.4.6. Inflammable
bowel disease (IBD) and irritable bowel syndrome (IBS)
17.7.3.4.7. Immune
Response
17.7.3.4.8. Others
17.7.3.5. Rest
of Latin America Probiotic Beverage Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
17.7.3.5.1. Online
17.7.3.5.2. Offline
17.7.3.5.2.1. Supermarket
17.7.3.5.2.2. Hypermarket
17.7.3.5.2.3. Convenience
Stores
17.7.3.5.2.4. Pharmacies
and Retail Stores
17.7.3.5.2.5. Others
17.8. Key
Segment for Channeling Investments
17.8.1. By
Country
17.8.2. By Type
17.8.3. By
Product
17.8.4. By
Strains
17.8.5. By
Indication
17.8.6. By
Distribution Channel
18. Competitive
Benchmarking
18.1. Market
Share Analysis, 2019
18.2. Global
Presence and Growth Strategies
18.2.1. Mergers
and Acquisitions
18.2.2. Product
Launches
18.2.3. Investments
Trends
18.2.4. R&D
Initiatives
19. Player
Profiles
19.1. Amul
19.1.1. Company
Details
19.1.2. Company
Overview
19.1.3. Product
Offerings
19.1.4. Key
Developments
19.1.5. Financial
Analysis
19.1.6. SWOT
Analysis
19.1.7. Business
Strategies
19.2. Biogaia
19.2.1. Company
Details
19.2.2. Company
Overview
19.2.3. Product
Offerings
19.2.4. Key
Developments
19.2.5. Financial
Analysis
19.2.6. SWOT Analysis
19.2.7. Business
Strategies
19.3. Bio-K
Plus International Inc.
19.3.1. Company
Details
19.3.2. Company
Overview
19.3.3. Product
Offerings
19.3.4. Key
Developments
19.3.5. Financial
Analysis
19.3.6. SWOT
Analysis
19.3.7. Business
Strategies
19.4. Danone
S.A.
19.4.1. Company
Details
19.4.2. Company
Overview
19.4.3. Product
Offerings
19.4.4. Key Developments
19.4.5. Financial
Analysis
19.4.6. SWOT
Analysis
19.4.7. Business
Strategies
19.5. Fonterra
Co-operative Group Limited
19.5.1. Company
Details
19.5.2. Company
Overview
19.5.3. Product
Offerings
19.5.4. Key
Developments
19.5.5. Financial
Analysis
19.5.6. SWOT
Analysis
19.5.7. Business
Strategies
19.6. Harmless
Harvest
19.6.1. Company
Details
19.6.2. Company
Overview
19.6.3. Product
Offerings
19.6.4. Key
Developments
19.6.5. Financial
Analysis
19.6.6. SWOT
Analysis
19.6.7. Business
Strategies
19.7. Lifeway
Foods, Inc.
19.7.1. Company
Details
19.7.2. Company
Overview
19.7.3. Product
Offerings
19.7.4. Key
Developments
19.7.5. Financial
Analysis
19.7.6. SWOT
Analysis
19.7.7. Business
Strategies
19.8. Nestle
19.8.1. Company
Details
19.8.2. Company
Overview
19.8.3. Product
Offerings
19.8.4. Key
Developments
19.8.5. Financial
Analysis
19.8.6. SWOT
Analysis
19.8.7. Business
Strategies
19.9. NextFoods
(Goodbelly)
19.9.1. Company
Details
19.9.2. Company
Overview
19.9.3. Product
Offerings
19.9.4. Key
Developments
19.9.5. Financial
Analysis
19.9.6. SWOT
Analysis
19.9.7. Business
Strategies
19.10. PepsiCo,
Inc. (Kevita)
19.10.1. Company
Details
19.10.2. Company
Overview
19.10.3. Product
Offerings
19.10.4. Key
Developments
19.10.5. Financial
Analysis
19.10.6. SWOT
Analysis
19.10.7. Business
Strategies
19.11. Tine BA
19.11.1. Company
Details
19.11.2. Company
Overview
19.11.3. Product
Offerings
19.11.4. Key
Developments
19.11.5. Financial
Analysis
19.11.6. SWOT Analysis
19.11.7. Business
Strategies
19.12. Valio
Ltd.
19.12.1. Company
Details
19.12.2. Company
Overview
19.12.3. Product
Offerings
19.12.4. Key
Developments
19.12.5. Financial
Analysis
19.12.6. SWOT
Analysis
19.12.7. Business
Strategies
19.13. Yakult
19.13.1. Company
Details
19.13.2. Company
Overview
19.13.3. Product
Offerings
19.13.4. Key
Developments
19.13.5. Financial
Analysis
19.13.6. SWOT
Analysis
19.13.7. Business Strategies
19.14. Other
Industry Participants
20. Key
Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.